Cargando…

Embelin, a small molecule quinone with a co-clinical power for castrate-resistant prostate cancer

Detalles Bibliográficos
Autor principal:	Poojari, Radhika J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126039/ https://www.ncbi.nlm.nih.gov/pubmed/25152733 http://dx.doi.org/10.3389/fphar.2014.00184

Ejemplares similares

Plant Derived Phytocompound, Embelin in CNS Disorders: A Systematic Review
por: Kundap, Uday P., et al.
Publicado: (2017)

Embelin Prevents Seizure and Associated Cognitive Impairments in a Pentylenetetrazole-Induced Kindling Zebrafish Model
por: Kundap, Uday Praful, et al.
Publicado: (2019)

Biochemical characterization and identification of ferulenol and embelin as potent inhibitors of malate:quinone oxidoreductase from Campylobacter jejuni
por: Kabongo, Augustin Tshibaka, et al.
Publicado: (2023)

PLGA: the smart therapeutics goods carrier
por: Poojari, Radhika J.
Publicado: (2013)

Natural Product-Based Studies for the Management of Castration-Resistant Prostate Cancer: Computational to Clinical Studies
por: Singla, Rajeev K., et al.
Publicado: (2021)

Advanced Therapeutic Options for Treatment of Metastatic Castration Resistant Prostatic Adenocarcinoma
por: Naseer, Faiza, et al.
Publicado: (2021)

Amelioration of Cognitive Deficit by Embelin in a Scopolamine-Induced Alzheimer’s Disease-Like Condition in a Rat Model
por: Bhuvanendran, Saatheeyavaane, et al.
Publicado: (2018)

A new method to quantify the effect of co-medication on the efficacy of abiraterone in metastatic castration-resistant prostate cancer patients
por: Fekete, Bertalan, et al.
Publicado: (2023)

Treatment-Emergent Co-Morbidities and Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone or Enzalutamide
por: Lin, Yi-Ting, et al.
Publicado: (2021)

Embelin Protects Against Acute Pentylenetetrazole-Induced Seizures and Positively Modulates Cognitive Function in Adult Zebrafish
por: Kundap, Uday Praful, et al.
Publicado: (2019)

Pharmacist-Urologist Collaborative Management Improves Clinical Outcomes in Patients With Castration-Resistant Prostate Cancer Receiving Enzalutamide
por: Hirabatake, Masaki, et al.
Publicado: (2022)

Cost-Effectiveness of Genomic Test-Directed Olaparib for Metastatic Castration-Resistant Prostate Cancer
por: Su, Dan, et al.
Publicado: (2021)

Integrated high-throughput analysis identifies super enhancers in metastatic castration-resistant prostate cancer
por: Zeng, Jie, et al.
Publicado: (2023)

Evaluation of the Efficacy of PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis
por: Wu, Kan, et al.
Publicado: (2021)

Alpha emitter radium-223 in patients with metastatic castration-resistant prostate cancer: A cost-utility analysis
por: Zeng, Xiaohui, et al.
Publicado: (2022)

Small Molecule Antagonists of the Nuclear Androgen Receptor for the Treatment of Castration-Resistant Prostate Cancer
por: Johnson, James K., et al.
Publicado: (2016)

Anti-plasmodial and Chloroquine Resistance Suppressive Effects of Embelin
por: Zaid, O.I., et al.
Publicado: (2017)

Ilicicolin A Exerts Antitumor Effect in Castration-Resistant Prostate Cancer Via Suppressing EZH2 Signaling Pathway
por: Guo, Lang, et al.
Publicado: (2021)

Geriatric Nutritional Risk Index as a Prognostic Marker for Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Docetaxel
por: Chang, Li-Wen, et al.
Publicado: (2021)

Stress Degradation Studies on Embelin
por: Ferreira, Galvina, et al.
Publicado: (2013)

Comparison of Systemic Treatments for Metastatic Castration-Resistant Prostate Cancer After Docetaxel Failure: A Systematic Review and Network Meta-analysis
por: Chen, Junru, et al.
Publicado: (2022)

Urolithin A analog inhibits castration-resistant prostate cancer by targeting the androgen receptor and its variant, androgen receptor-variant 7
por: Chandrasekaran, Balaji, et al.
Publicado: (2023)

Increased Tumoral Microenvironmental pH Improves Cytotoxic Effect of Pharmacologic Ascorbic Acid in Castration-Resistant Prostate Cancer Cells
por: Li, Zhoulei, et al.
Publicado: (2020)

Computational studies reveal mechanism by which quinone derivatives can inhibit SARS-CoV-2. Study of embelin and two therapeutic compounds of interest, methyl prednisolone and dexamethasone
por: Caruso, Francesco, et al.
Publicado: (2020)

The Application of Embelin for Cancer Prevention and Therapy †
por: Ko, Jeong-Hyeon, et al.
Publicado: (2018)

Anti-Alzheimer activity of isolated karanjin from Pongamia pinnata (L.) pierre and embelin from Embelia ribes Burm.f.
por: Saini, Prachi, et al.
Publicado: (2017)

Mechanism of Action of Small-Molecule Agents in Ongoing Clinical Trials for SARS-CoV-2: A Review
por: Zhao, Lei, et al.
Publicado: (2022)

First Line Androgen Deprivation Therapy Duration Is Associated with the Efficacy of Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer after Docetaxel
por: Li, Jian-Ri, et al.
Publicado: (2017)

Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients after Docetaxel
por: Li, Jian-Ri, et al.
Publicado: (2017)

Pyrroloquinoline quinone modulates YAP-related anti-ferroptotic activity to protect against myocardial hypertrophy
por: Zhou, Jiabin, et al.
Publicado: (2022)

XIAP Antagonist Embelin Inhibited Proliferation of Cholangiocarcinoma Cells
por: Wehrkamp, Cody J., et al.
Publicado: (2014)

Embelin binds to human neuroserpin and impairs its polymerisation
por: Saga, Giorgia, et al.
Publicado: (2016)

Embelin as Lead Compound for New Neuroserpin Polymerization Inhibitors
por: Visentin, Cristina, et al.
Publicado: (2020)

Pharmacological evaluation of embelin - chitosan nanoparticles as an antidiabetic agent
por: Maanvizhi, Saba, et al.
Publicado: (2022)

Synthesis of Quinoline and Dihydroquinoline Embelin Derivatives as Cardioprotective Agents
por: Martín-Acosta, Pedro, et al.
Publicado: (2023)

Safety and Immunogenicity of a Human Epidermal Growth Factor Receptor 1 (HER1)-Based Vaccine in Prostate Castration-Resistant Carcinoma Patients: A Dose-Escalation Phase I Study Trial
por: Caballero, Iraida, et al.
Publicado: (2017)

A TLC Identification and Spectrophotometric Estimation of Embelin in Embelia ribes
por: Chauhan, S. K., et al.
Publicado: (1999)

Improving power in PSA response analyses of metastatic castration-resistant prostate cancer trials
por: Grayling, Michael J., et al.
Publicado: (2022)

Antimalarial and antitumour activities of the steroidal quinone-methide celastrol and its combinations with artemiside, artemisone and methylene blue
por: Ng, Jerome P. L., et al.
Publicado: (2022)

Small Molecule Inhibitors of CRM1
por: Ferreira, Bibiana I., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sj5u85dm9d3cbngl2n7bnl7lj8